Child Behavior Disorders: Clinical Trials

3 trials for Child Behavior Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Child Behavior Disorders: new trials by email Literature Review of Child Behavior Disorders trials Research Report on Child Behavior Disorders

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Family Health and Development Project
Intensive In-home Child and Adolescent Psychiatric Service, Home-based Child Treatment Coordination - Serious Emotional Disturbance
Phase 3CompletedYale University1102011-05-012016-10-14
Promoting Infant Mental Health in Foster Care
Promoting First Relationships Program, Early Education Support Program - Child Development, Child Behavior Disorders
Phase 2 / Phase 3CompletedUniversity of Washington2362007-04-012012-05-17
A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children
risperidone - Learning Disorders, Child Behavior Disorders
Phase 3CompletedJanssen-Cilag Ltd.192003-09-012011-05-20

Narrower conditions

Learning Disabilities (1)  ·  Mental Disorders (1)  ·  Reactive Attachment Disorder (1)

Broader conditions

Neurodevelopmental Disorders (3)  ·  Mental Disorders (2)  ·  Communication Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Risperidone (1)

Sponsors

Janssen-Cilag Ltd. (1)  ·  University of Washington (1)  ·  Yale University (1)

Countries

United States (2)

Top investigators

Joseph L. Woolston, M.D. (1)  ·  Susan J. Spieker, PhD (1)

NIH funding

R01MH077329 (1)